Condensed Statements Of Operations (USD $) Share data in Thousands, except Per Share data, unless otherwise specified	3 Months Ended
	Sep. 30, 2013	Sep. 30, 2012
Condensed Statements Of Operations [Abstract]
SALES	$ 3,779,000	$ 3,970,000
COST OF GOODS SOLD	1,915,000	1,954,000
Gross profit	1,864,000	2,016,000
COSTS AND EXPENSES
Sales and marketing	1,845,000	1,717,000
General and administrative	685,000	738,000
Research and development	421,000	615,000
Change in value of acquisition consideration	(9,000)	(154,000)
Medical device tax	61,000
Amortization of identifiable intangible assets	23,000	26,000
Total costs and expenses	3,026,000	2,942,000
OPERATING LOSS	(1,162,000)	(926,000)
INTEREST EXPENSE	(161,000)	(123,000)
FOREIGN CURRENCY EXCHANGE LOSS/(GAIN)	1,000	(4,000)
LOSS BEFORE INCOME TAXES	(1,322,000)	(1,053,000)
INCOME TAX EXPENSE	12,000	16,000
NET LOSS	$ (1,334,000)	$ (1,069,000)
NET LOSS PER COMMON SHARE - BASIC	$ (0.06)	$ (0.05)
NET LOSS PER COMMON SHARE - DILUTED	$ (0.06)	$ (0.05)
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING - BASIC	21,020	20,180
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING - DILUTED	21,020	20,180